Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 13, 2018 - Issue
Submit an article Journal homepage
80
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Cost-effectiveness of roflumilast as an add-on to triple inhaled therapy vs triple inhaled therapy in patients with severe and very severe COPD associated with chronic bronchitis in the UK

Chris Kiff1 ICON plc, Abingdon, UK
,
Sandrine Ruiz2 AstraZeneca, Barcelona, Spain, [email protected]Correspondence[email protected]
,
Nebibe Varol3 AstraZeneca, Cambridge, UK
,
Danny Gibson4 AstraZeneca, Luton, UK
,
Andrew Davies1 ICON plc, Abingdon, UK
&
Debasree Purkayastha5 Phastar, Manchester, UK
Pages 2707-2720 | Published online: 03 Sep 2018

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.